267 related articles for article (PubMed ID: 17581794)
1. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells.
Zhou HJ; Wang WQ; Wu GD; Lee J; Li A
Vascul Pharmacol; 2007; 47(2-3):131-8. PubMed ID: 17581794
[TBL] [Abstract][Full Text] [Related]
2. Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell.
Huan-huan C; Li-Li Y; Shang-Bin L
Cancer Lett; 2004 Aug; 211(2):163-73. PubMed ID: 15219940
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
Chen HH; Zhou HJ; Wu GD; Lou XE
Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells.
Lee J; Zhou HJ; Wu XH
Cancer Chemother Pharmacol; 2006 Jan; 57(2):213-20. PubMed ID: 16075280
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro.
Xiao Z; Wang Y; Lu L; Li Z; Peng Z; Han Z; Hao Y
Leuk Res; 2006 Jan; 30(1):54-9. PubMed ID: 15982734
[TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.
Ebos JM; Tran J; Master Z; Dumont D; Melo JV; Buchdunger E; Kerbel RS
Mol Cancer Res; 2002 Dec; 1(2):89-95. PubMed ID: 12496355
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of human umbilical vein endothelial cells induced by artesunate.
Wu GD; Zhou HJ; Wu XH
Vascul Pharmacol; 2004 Jul; 41(6):205-12. PubMed ID: 15653096
[TBL] [Abstract][Full Text] [Related]
8. [Dihydroartemisinin inhibits the expression of vascular endothelial growth factor in K562 cells].
Li J; Zhou HJ
Yao Xue Xue Bao; 2005 Nov; 40(11):1041-5. PubMed ID: 16499092
[TBL] [Abstract][Full Text] [Related]
9. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence.
He R; Liu B; Yang C; Yang RC; Tobelem G; Han ZC
Cancer Gene Ther; 2003 Dec; 10(12):879-86. PubMed ID: 14712314
[TBL] [Abstract][Full Text] [Related]
11. [Angiogenesis in different clinical phases of chronic myeloid leukemia].
Krasowska-Kwiecień A; Kijowski J; Łukasiewicz E; Sacha T; Foryciarz K; Majka M; Ratajczak MZ; Skotnicki AB
Przegl Lek; 2009; 66(9):471-8. PubMed ID: 21033405
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
[TBL] [Abstract][Full Text] [Related]
13. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo.
Niu YC; Liu JC; Zhao XM; Wu XX
Oncol Rep; 2009 Jan; 21(1):145-52. PubMed ID: 19082455
[TBL] [Abstract][Full Text] [Related]
14. Amifostine inhibits angiogenesis in vivo.
Giannopoulou E; Katsoris P; Kardamakis D; Papadimitriou E
J Pharmacol Exp Ther; 2003 Feb; 304(2):729-37. PubMed ID: 12538828
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell response to lactate: implication of PAR modification of VEGF.
Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
[TBL] [Abstract][Full Text] [Related]
16. Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice.
Ruan GR; Liu YR; Chen SS; Fu JY; Chang Y; Qin YZ; Li JL; Yu H; Wang H
Leuk Res; 2004 Jul; 28(7):763-9. PubMed ID: 15158098
[TBL] [Abstract][Full Text] [Related]
17. [The down regulation of VEGF gene expression may link to change the expression profile of genes in leukemia cell line K562].
Xu WL; Shen HL; Wu ZY; Tang HR; Wang FC
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):37-42. PubMed ID: 16456783
[TBL] [Abstract][Full Text] [Related]
18. [Anti-angiogenesis of interferon-alpha2b in chronic myeloid leukemia in vitro].
Zhang LM; Yu YZ; Huang ZP; Zhang WS; Dong L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):291-5. PubMed ID: 20416154
[TBL] [Abstract][Full Text] [Related]
19. [Effect of triptolide on expression of urokinase-type plasminogen activators in vascular endothelial cells].
Ding Y; Zhang J; Zhao QL; Hou LJ; Wang QL; Wang SR
Ai Zheng; 2005 Jul; 24(7):801-5. PubMed ID: 16004804
[TBL] [Abstract][Full Text] [Related]
20. Chrysin inhibits lipopolysaccharide-induced angiogenesis via down-regulation of VEGF/VEGFR-2(KDR) and IL-6/IL-6R pathways.
Lin CM; Chang H; Li SY; Wu IH; Chiu JH
Planta Med; 2006 Jun; 72(8):708-14. PubMed ID: 16732516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
